Earnings Forecast of Novavax, Inc. (NVAX)

The average volume of a stock suggests the liquidity of a particular company. Its traded volume of 4.5 Million shares made it active as comparison to average volume of 6558.21.

Heading into the stock price potential, Novavax, Inc. needs to grow just 45.63% to cross its median price target of $1.5. Thanks to a rise of nearly 17.2% in the past five days, the stock price is now down -13.49% so far on the year - still in weak territory. Sometimes, companies with strong fundamentals but with low annualized EPS of less than 4 or 5 % but analysts may talk about a huge turnaround in the earnings due to heavy order book. Latest closing price was -2.85% below its 50-day moving average and -56.05% below its 200-day moving average. The stock's market cap is $308.03 million.

For the past 5 years, Synergy Pharmaceuticals Inc.'s EPS growth has been almost -31.8%. During the same period previous year, the company earned ($0.29) earnings per share. The firm earned $5.40 million during the quarter, compared to analysts' expectations of $5.45 million. Presently, it has a Return on Equity (ROE) of -787.40%. The business's revenue for the quarter was up 34.6% on a year-over-year basis. For passive investors (long-term) earnings per shares and its growth is most valuable indicator for investment, as ICLR has EPS growth of 17.00% for this year while, NVAX standing at -72.80%.

Sigurdsson should remember Tottenham spell before leaving Swansea - Clement
He's been outstanding and he managed to change the mood, the atmosphere and the confidence of the team. It's down to the club if they want to sell me.

Novavax, Inc. (NVAX) now has a Return on Assets (ROA) value of -56.7 Percent.

Several brokerages recently weighed in on NVAX. Finally, FBR & Co reaffirmed an "outperform" rating and issued a $12.00 target price on shares of Novavax in a report on Wednesday, January 18th.

The number of shares now held by investors is 282.61 Million. Zacks Investment Research cut Novavax from a "hold" rating to a "sell" rating in a research note on Saturday, January 21st. 3,055,541 shares of the company were exchanged.

1 firefighter killed, 2 seriously hurt in San Antonio fire
Be proactive - Use the "Flag as Inappropriate" link at the upper right corner of each comment to let us know of abusive posts. San Antonio Fire Department Chief Charles Hood confirmed the death of Scott Deem, a six-year veteran of the department.

Novavax, Inc. was covered by a number of analysts recently, 1 rated the stock as Buy, 6 rated Hold, 0 rated sell and 0 gave an Underperform. The company now has a consensus rating of "Hold" and a consensus price target of $5.61.

In other news, insider Stanley C. Erck purchased 50,000 shares of the company's stock in a transaction that occurred on Thursday, May 11th. The return on invested capital at 0%, which is good, compared to its peers. State Street Corp now owns 19,971,040 shares of the biopharmaceutical company's stock worth $25,163,000 after buying an additional 9,947,481 shares during the last quarter. The purchase was disclosed in a document filed with the SEC, which is accessible through this hyperlink. Leading up to this report, we have seen a 24.1% rise in the stock price over the last 30 days and a -36.42% decline over the past 3 months. Corporate insiders own 3.50% of the company's stock. In current trading day Zoetis Inc. (NVAX) has weekly volatility of 12.89%% while its monthly volatility value is at 7.93%%. Piermont Capital Management Inc. increased its position in Novavax by 9.2% in the third quarter. The Beta factor for the stock is listed at 1.02.

Novavax, Inc.is a clinical-stage vaccine company focused on the discovery, development and commercialization of recombinant nanoparticle vaccines and adjuvants. JPMorgan Chase & Co. boosted its stake in Novavax by 110.5% in the third quarter. Two Sigma Securities LLC acquired a new position in shares of Novavax during the third quarter valued at approximately $751,000.

Roadside bomb kills 11; attacks kill 10 Afghan policeman
He said the assault took place in Tagab district, adding that 10 Taliban fighters were also killed, including two commanders. He said ten of the Taliban militants taking part in the attack were killed by Afghan forces.

Related news